Literature DB >> 20362555

Diverse FGF receptor signaling controls astrocyte specification and proliferation.

Kyungjun Kang1, Mi-Ryoung Song.   

Abstract

During CNS development, pluripotency neuronal progenitor cells give rise in succession to neurons and glia. Fibroblast growth factor-2 (FGF-2), a major signal that maintains neural progenitors in the undifferentiated state, is also thought to influence the transition from neurogenesis to gliogenesis. Here we present evidence that FGF receptors and underlying signaling pathways transmit the FGF-2 signals that regulate astrocyte specification aside from its mitogenic activity. Application of FGF-2 to cortical progenitors suppressed neurogenesis whereas treatment with an FGFR antagonist in vitro promoted neurogenesis. Introduction of chimeric FGFRs with mutated tyrosine residues into cortical progenitors and drug treatments to specifically block individual downstream signaling pathways revealed that the overall activity of FGFR rather than individual autophosphorylation sites is important for delivering signals for glial specification. In contrast, a signal for cell proliferation by FGFR was mainly delivered by MAPK pathway. Together our findings indicate that FGFR activity promotes astrocyte specification in the developing CNS. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20362555     DOI: 10.1016/j.bbrc.2010.03.174

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  ERBB3-mediated regulation of Bergmann glia proliferation in cerebellar lamination.

Authors:  Anupama Sathyamurthy; Dong-Min Yin; Arnab Barik; Chengyong Shen; Jonathan C Bean; Dwight Figueiredo; Jin-Xiong She; Wen-Cheng Xiong; Lin Mei
Journal:  Development       Date:  2015-01-06       Impact factor: 6.868

2.  Spinal astrocytic FGFR3 activation leads to mechanical hypersensitivity by increased TNF-α in spared nerve injury.

Authors:  Ke-Yu Xie; Qiang Wang; De-Jun Cao; Jia Liu; Xian-Feng Xie
Journal:  Int J Clin Exp Pathol       Date:  2019-08-01

3.  Reproductive dysfunction and decreased GnRH neurogenesis in a mouse model of CHARGE syndrome.

Authors:  Wanda S Layman; Elizabeth A Hurd; Donna M Martin
Journal:  Hum Mol Genet       Date:  2011-05-19       Impact factor: 6.150

4.  Characterization of tunable FGF-2 releasing polyelectrolyte multilayers.

Authors:  Mara L Macdonald; Natalia M Rodriguez; Nisarg J Shah; Paula T Hammond
Journal:  Biomacromolecules       Date:  2010-08-09       Impact factor: 6.988

5.  Neuron-glia interactions through the Heartless FGF receptor signaling pathway mediate morphogenesis of Drosophila astrocytes.

Authors:  Tobias Stork; Amy Sheehan; Ozge E Tasdemir-Yilmaz; Marc R Freeman
Journal:  Neuron       Date:  2014-07-16       Impact factor: 17.173

6.  Astrocyte-like cells derived from human oral mucosa stem cells provide neuroprotection in vitro and in vivo.

Authors:  Javier Ganz; Ina Arie; Tali Ben-Zur; Michal Dadon-Nachum; Sammy Pour; Shareef Araidy; Sandu Pitaru; Daniel Offen
Journal:  Stem Cells Transl Med       Date:  2014-01-29       Impact factor: 6.940

7.  PLZF regulates fibroblast growth factor responsiveness and maintenance of neural progenitors.

Authors:  Zachary B Gaber; Samantha J Butler; Bennett G Novitch
Journal:  PLoS Biol       Date:  2013-10-08       Impact factor: 8.029

Review 8.  Astrocyte Differentiation of Human Pluripotent Stem Cells: New Tools for Neurological Disorder Research.

Authors:  Abinaya Chandrasekaran; Hasan X Avci; Marcel Leist; Julianna Kobolák; Andras Dinnyés
Journal:  Front Cell Neurosci       Date:  2016-09-26       Impact factor: 5.505

9.  Monitoring local synaptic activity with astrocytic patch pipettes.

Authors:  Christian Henneberger; Dmitri A Rusakov
Journal:  Nat Protoc       Date:  2012-11-29       Impact factor: 13.491

10.  STAT3 but not STAT1 is required for astrocyte differentiation.

Authors:  Seulgi Hong; Mi-Ryoung Song
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.